We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Industry

Image:  Transasia Bio-Medicals’s Mr. Suresh Vazirani, CMD, and Ms. Mala Vazirani, Executive Director, receives the “Global Growth Company-2014” award from Mr. David Aikam, Managing Director, Head of New Champions, World Economic Forum (Photo courtesy of Transasia Bio-Medicals Ltd.).

WEF Selects Transasia Bio-Medicals for Global Growth Company Award

Leading in vitro diagnostics company Transasia Bio-Medicals has been selected as “Global Growth Company-2014” by the World Economic Forum, comprising top global enterprises.   More...
08 Jan 2015

Testing On Tissues and Cells Sector Reaches USD 7.5 Billion

Driven by new technologies and the need to discover biomarkers, the tissue and cell-based diagnostic market grew to an estimated USD 7.4 billion in revenues in 2013 for in vitro diagnostic and other reagents used by clinical laboratories, according to a new report from Kalorama Information.  More...
05 Jan 2015
Caption: The “Sofia Strep A+ FIA” test for rapid Group A Streptococcus detection has received the first simultaneous FDA clearance and CLIA waiver via the FDA’s new Dual Submission Program (Image courtesy of Quidel Corporation).

Bacterial Infection Assay Receives First Simultaneous FDA Clearance and CLIA Waiver

A Group A Streptococcus diagnostic test from Quidel Corporation has received the first-ever simultaneous FDA clearance and CLIA waiver via the new, time- and cost-saving Dual Submission Program of the United States Food and Drug Administration.  More...
04 Jan 2015

Strong Growth Forecasted for Women's Health Diagnostics

Key women's health diagnostics are showing strong growth worldwide, according to healthcare market researcher Kalorama Information, including, among others, the sectors for digital mammography, lab-based fertility testing, and bone densitometry.   More...
28 Dec 2014

Merger Expected to Accelerate Development of Personalized Medicine Solutions

Acquisition of an American company specializing in data management and analysis by a worldwide leader in genomics research and diagnostics development is expected to decrease the complexity, time, and cost of genomic analysis and accelerate development of the science of personalized medicine.  More...
28 Dec 2014

Diagnostics Rapidly Gain Ground in Infectious Diseases Sector

According to a new Frost & Sullivan analysis, convergence of immunological and molecular tests will help meet growing needs for infectious disease diagnostics. Although these tests remain expensive, their efficiency and accuracy strengthen their use case.   More...
22 Dec 2014

Robot-Assisted PCR Among Innovations Driving qPCR Sector

Seeking efficiency in the qPCR process, a number of automation and robotics technologies have been added to product offerings from top competitors. According to the new Kalorama Information report “qPCR and dPCR Markets: Clinical and Research Markets,” this is one factor driving the usefulness of this workhorse lab technology.  More...
21 Dec 2014
New
Gold Member
Aspiration System
VACUSAFE
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Manual Pipetting Aid
Pipette Controllers macro
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000-2026 Globetech Media. All rights reserved.